Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Gainesville › NPI 1174579155
Hospital

North Florida Regional Medical Center, INC.

North Florida Regional Medical Center, INC. was paid $21.85M by Medicaid between Jan 2018 and Dec 2024, across 237 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.

33Billing provider infoNORTH FLORIDA REGIONAL MEDICAL CENTER, INC.
GAINESVILLE, FL 32605
33aNPI1174579155assigned 05/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$21.85M
24GClaims861,660
24DCodes billed237
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#13 of 163
Median peer was paid$4.77M
This provider vs. median4.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201870,380$788K
2019133,606$1.87M
2020141,950$2.39M
2021195,866$4.87M
2022192,736$6.33M
202391,208$3.62M
2024incomplete35,914$1.98M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 29% 69,868 63,766 $6.38M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 53,541 46,677 $4.32M
74177 Computed tomography, abdomen and pelvis; with contrast material 6.2% 7,443 6,649 $1.36M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.0% 13,819 12,797 $1.32M
80053 Comprehensive metabolic panel 3.9% 40,300 31,816 $854K
70450 Computed tomography, head or brain; without contrast material 3.9% 8,278 7,017 $844K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.9% 11,163 9,057 $629K
71275 Computed tomographic angiography, chest, with contrast material 2.5% 3,007 2,597 $546K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.3% 3,522 3,085 $502K
80048 Basic metabolic panel (calcium, ionized) 1.5% 13,881 10,467 $323K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.4% 2,993 2,834 $317K
96361 Intravenous infusion, hydration; each additional hour 1.4% 3,139 2,695 $302K
225 more codes
59025 Fetal non-stress test 1.2% 5,189 $256K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.1% 19,457 $232K
A9270 Non-covered item or service <1% 26,051 $164K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 2,048 $164K
72125 Computed tomography, cervical spine; without contrast material <1% 3,126 $138K
72131 <1% 2,495 $128K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,918 $114K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,330 $113K
G0378 Hospital observation service, per hour <1% 13,176 $109K
J7050 Infusion, normal saline solution, 250 cc <1% 5,319 $102K
86850 <1% 2,972 $96K
81003 <1% 33,955 $91K
87070 <1% 8,492 $83K
85027 <1% 56,403 $78K
84702 <1% 4,523 $75K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,316 $74K
36415 Collection of venous blood by venipuncture <1% 3,578 $73K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,179 $71K
70496 <1% 408 $66K
58661 <1% 41 $66K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 4,196 $56K
93976 <1% 4,305 $56K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 6,325 $55K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 390 $55K
86403 <1% 3,781 $52K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 342 $50K
76830 Ultrasound, transvaginal <1% 4,252 $49K
10060 <1% 880 $45K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,621 $44K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 25,605 $42K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,042 $38K
71045 Radiologic examination, chest; single view <1% 15,432 $37K
73610 <1% 1,672 $37K
81025 <1% 13,037 $34K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,934 $33K
71046 Radiologic examination, chest; 2 views <1% 6,289 $33K
J7030 Infusion, normal saline solution , 1000 cc <1% 20,283 $31K
12001 <1% 486 $31K
87449 <1% 2,284 $31K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,308 $30K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,641 $30K
73130 <1% 1,588 $30K
73562 <1% 1,830 $28K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,239 $28K
73630 <1% 1,929 $27K
84484 <1% 17,447 $27K
85014 <1% 442 $27K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,998 $26K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,322 $25K
J1644 Injection, heparin sodium, per 1000 units <1% 6,919 $25K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,494 $25K
72128 <1% 298 $24K
84703 <1% 5,373 $24K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,689 $24K
73030 <1% 1,596 $23K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 18,834 $22K
71250 <1% 470 $20K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,488 $19K
C1769 Guide wire <1% 1,644 $18K
73110 <1% 914 $17K
96375 Therapeutic injection; each additional sequential IV push <1% 6,690 $16K
87040 <1% 5,487 $16K
86900 <1% 4,010 $16K
85610 <1% 8,326 $16K
87077 <1% 3,160 $15K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 671 $15K
93971 <1% 1,608 $14K
83690 <1% 13,006 $14K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 27 $14K
82550 <1% 4,264 $14K
83735 <1% 13,052 $14K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,241 $11K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 363 $11K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 8,285 $10K
12011 <1% 183 $10K
12002 <1% 202 $10K
70486 <1% 397 $10K
85730 <1% 6,795 $10K
J2704 Injection, propofol, 10 mg <1% 1,473 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,296 $9K
83880 <1% 4,811 $9K
93970 <1% 855 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,629 $8K
84112 <1% 157 $8K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 923 $8K
93017 <1% 512 $8K
73080 <1% 602 $8K
70491 <1% 42 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,504 $7K
76770 <1% 175 $7K
76937 <1% 457 $7K
J1815 Injection, insulin, per 5 units <1% 2,667 $7K
80061 Lipid panel <1% 2,814 $7K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,541 $6K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 90 $5K
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) <1% 283 $5K
84443 Thyroid stimulating hormone (TSH) <1% 4,119 $5K
82553 <1% 1,950 $5K
83605 <1% 5,037 $5K
87205 <1% 1,176 $5K
73140 <1% 290 $5K
73590 <1% 333 $5K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 115 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,373 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,854 $4K
72100 <1% 515 $4K
84100 <1% 3,169 $4K
70498 <1% 376 $4K
87186 <1% 2,639 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,529 $4K
85379 <1% 2,576 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 14,730 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 1,543 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 28 $3K
90715 <1% 1,215 $3K
00840 <1% 248 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,419 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,342 $3K
82731 <1% 13 $3K
74018 <1% 465 $3K
82607 <1% 1,507 $3K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 139 $3K
86901 <1% 3,894 $3K
80076 <1% 3,435 $3K
73502 <1% 357 $3K
83986 <1% 135 $3K
97161 <1% 181 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,520 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 877 $2K
73090 <1% 210 $2K
J7999 Compounded drug, not otherwise classified <1% 81 $2K
87807 <1% 1,600 $2K
80047 <1% 29 $2K
64400 <1% 13 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 71 $1K
76641 <1% 29 $1K
86140 <1% 1,017 $1K
70551 Magnetic resonance imaging, brain; without contrast material <1% 50 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 449 $1K
84439 <1% 1,483 $1K
82248 <1% 1,706 $1K
82077 <1% 588 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 247 $1K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 49 $932.82
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 537 $930.05
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,669 $888.42
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,728 $875.61
97116 <1% 267 $870.94
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 996 $867.54
97535 Self-care/home management training, each 15 minutes <1% 447 $832.94
83540 <1% 377 $806.95
82728 <1% 251 $750.81
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 791 $705.68
82570 <1% 660 $659.15
83550 <1% 260 $649.66
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 257 $640.46
J2060 Injection, lorazepam, 2 mg <1% 1,025 $587.83
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 291 $575.77
77067 Screening mammography, bilateral, including computer-aided detection <1% 17 $570.52
82565 <1% 31 $568.86
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 2,239 $478.21
82803 <1% 105 $457.16
97162 <1% 68 $431.86
80320 <1% 121 $429.60
72072 <1% 29 $402.81
84156 <1% 559 $388.91
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 173 $367.77
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 170 $293.35
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 448 $262.16
J3490 Unclassified drugs <1% 182 $244.21
85651 <1% 429 $220.01
87400 <1% 2,080 $210.92
72040 <1% 30 $210.81
85520 <1% 788 $209.62
88302 <1% 30 $191.70
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 299 $190.39
88304 <1% 116 $158.45
72170 <1% 15 $152.69
73552 <1% 33 $152.69
29125 <1% 143 $146.17
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,272 $138.02
76818 <1% 12 $135.83
88307 <1% 60 $126.07
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 699 $122.02
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,628 $118.18
90662 <1% 187 $115.61
J1940 Injection, furosemide, up to 20 mg <1% 76 $113.13
J0780 Injection, prochlorperazine, up to 10 mg <1% 565 $112.90
82746 <1% 293 $91.41
J0692 Injection, cefepime hydrochloride, 500 mg <1% 464 $90.00
G0008 Administration of influenza virus vaccine <1% 272 $87.24
84550 <1% 172 $63.55
87430 <1% 729 $44.51
J3475 Injection, magnesium sulfate, per 500 mg <1% 140 $38.48
J0561 Injection, penicillin g benzathine, 100,000 units <1% 68 $33.65
87081 <1% 14 $23.01
J1650 Injection, enoxaparin sodium, 10 mg <1% 484 $15.00
82140 <1% 78 $6.68
73660 0% 12 $0.00
99153 Mod sedat endo service >5yrs 0% 30 $0.00
96376 0% 584 $0.00
87147 0% 41 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 78 $0.00
J3535 Drug administered through a metered dose inhaler 0% 26 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 44 $0.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 0% 144 $0.00
A6257 Transparent film, sterile, 16 sq. in. or less, each dressing 0% 150 $0.00
97166 0% 19 $0.00
82330 0% 41 $0.00
82150 0% 16 $0.00
87340 0% 14 $0.00
83615 0% 16 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 15 $0.00
90686 0% 16 $0.00
85384 0% 77 $0.00
S0028 Injection, famotidine, 20 mg 0% 849 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 331 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 0% 12 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 134 $0.00
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 0% 18 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 88 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 55 $0.00
82009 0% 63 $0.00
C1758 Catheter, ureteral 0% 16 $0.00
99152 0% 29 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialREDD-HACHEY, KRISTY (CFO)